The collagen crosslinks pyridinoline and deoxypyridinoline: A review of their biochemistry, physiology, measurement, and clinical applications

Journal of Clinical Ligand Assay

Volumn 21, Issue 2, 1998, Pages 102-110

  Fraser, William D ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Collagen Crosslinks; Deoxypyridinoline; Pyridinoline

Indexed keywords

COLLAGEN; DEOXYPYRIDINOLINE; PYRIDINOLINE;

ARTICLE; BLOOD LEVEL; BONE TURNOVER; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE SUBSTITUTION; HUMAN; IMMUNOASSAY; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PROTEIN ANALYSIS; PROTEIN CROSS LINKING;

EID: 0032467319     PISSN: 10811672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (114)

1. Eyre DR, Paz MA, Gallop PM: Crosslinking in collagen and elastin. Annu Rev Biochem 1984;53:717-748.
2. Fujimoto D, Akiba K, Nakamura N: Isolation and characterization of a fluorescent material in bovine achilles tendon collagen. Biochem Biophys Res Commun 1977;76:1124-1129.
3. Eyre DR: Crosslink maturation in bone collagen. In Veiss A (ed): The Chemistry and Biology of Mineralized Connective Tissues. New York, Elsevier North-Holland, 1981, pp 51-55.
4. Yamauchi M, Katz EP, Mechanic GL: Intermolecular cross-linking and stereospecific molecular packing in type I collagen fibrils of the periodontal ligament. Biochem 1986;25:4907-4913.
5. Robins SP, Duncan A: Cross-linking of collagen: Location of pyridinoline in bovine articular cartilage at two sites of the molecule. Biochem J 1983;215:175-182.
6. Ogawa T, Ono T, Tsuda M, et al: A novel fluor in insoluble collagen: A crosslinking moiety in collagen molecules. Biochem Biophys Res Commun 1982;107:1252-1257.
7. Fujimoto D, Moriguchi T, Ishida T, et al: The structure of pyridinoline, a collagen crosslink. Biochem Biophys Res Commun 1978;84:52-57.
8. Robins SP: Analysis of the crosslinking components in collagen and elastin. Methods Biochem Anal 1982;28:329-379.
9. Byre DR: Collagen crosslinking amino acids. Methods Enzymol 1987;144:115-139.
10. Blumsohn A, Colwell A, Naylor K, et al: The effect of light and gamma irradiation on pyridinolines and telopeptides of type I collagen in urine. Clin Chem 1995;41:1195-1197.
11. Steinmann B, Royce PM, Superti-Furga A: The Ehlers-Danlos syndrome. In Royce PM, Steinmann B (eds): Connective Tissue and Its Heritable Disorders. New York, Wiley-Liss, 1993, pp 351-407.
12. Kirsche E, Kreig T, Remberger K, et al: Disorder of collagen metabolism in a patient with osteogenesis imperfecta (lethal type) - increased degree of hydroxylation of lysine in collagen type I and type III. J Clin Invest 1981;11:39-47.
13. Bailey AJ, Wotton SF, Sims TJ, et al: Post-translational modifications in the collagen of human osteoporotic femoral head. Biochem Biophys Res Commun 1992;185:801-805.
14. Batge B, Diebold J, Stein H, et al: Compositional analysis of the collagenous bone matrix - A study on adult normal and osteopenic bone tissue. Eur J Clin Invest 1992;22:805-812.
15. Glimcher MJ, Shapiro F, Ellis RD, et al: Changes in tissue morphology and collagen composition during the repair of cortical bone in the adult chicken. J Bone Joint Surg 1980;62A:964-973.
16. Steinmann B, Bruckner P, Superti-Furga A: Cyclosporin A slows collagen triple-helix formation in vivo: Indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase. J Biol Chem 1991;266:1299-1303.
17. Henkel W, Glanville RW, Greifendorf D: Characterisation of a type-1 collagen trimeric cross-linked peptide from calf aorta and its cross-linked structure. Eur J Biochem 1987;165:427-436.
18. Knott L, Whitehead CC, Fleming RH, et al: Biochemical changes in the collagenous matrix of osteoporotic avian bone. Biochem J 1995;310:1045-1051.
19. Hanson DA, Eyre DR: Molecular site specificity of pyridinoline and pyrrole crosslinks in type-I collagen of human bone. J Biol Chem 1996;271:26508-26516.
20. Eyre DR, Koob TJ, Van Ness KP: Quantitation of hydroxypyridinium cross-links in collagen by high performance liquid chromatography. Anal Biochem 1984;137:380-388.
21. Eyre DR, Dickson IR, Van Ness K: Collagen cross-linking in human bone and articular cartilage. Biochem J 1988;252:495-500.
22. Seibel MJ, Robins SP, Bilezikian JP: Urinary hydroxypyridinium cross-links of collagen: specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 1992;3:263-270.
23. Walters C, Eyre DR: Collagen cross-links in human dentin: Increasing content of hydroxypyridinium residues with age. Calcif Tissue Int 1983;35:401-405.
24. Foged NT, Delaisse J-M, Hou P, et al: Quantitation of the collagenolytic activity of isolated osteoclasts by enzyme-linked immunosorbent assay. J Bone Miner Res 1996;11:226-237.
25. Apone S, Lee MY, Eyre DR: Osteoclasts generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human bone. Bone 1997;21:129-136.
26. Colwell A, Eastell R: The renal clearance of free and conjugated pyridinium cross-links of collagen. J Bone Miner Res 1996;11:1976-1980.
27. Delmas PD, Schlemmer A, Gineyts E, et al: Urinary excretion of pyridinoline cross-links correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 1991;6:639-644.
28. Roux JP, Arlot ME, Gineyts E, et al: Automatic-Interactive measurements of resorption cavities in transiliac bone biopsies and correlation with deoxypyridinoline. Bone 1995;17:153-156.
29. Eastell R, Hampton L, Colwell A, et al: Urinary collagen crosslinks are highly correlated with radioisotopic measurements of bone resorption. In Christiansen C, Overgaard K (eds): Osteoporosis 1990: Proceedings of the Third International Symposium on Osteoporosis. Copenhagen, Osteopress ApS, 1990, pp 469-470.
30. Eastell R, Colwell A, Hampton L, et al: Biochemical markers of bone resorption compared with estimates of bone resorption from radio tracer kinetic studies in osteoporosis. J Bone Miner Res 1997;12:59-65.
31. Colwell A, Eastell R, Assiri AMA, et al: Effect of diet on deoxypyridinoline excretion. In Christiansen C, Overgaard K (eds): Osteoporosis 1990: Proceedings of the Third International Symposium on Osteoporosis. Copenhagen, Osteopress ApS, 1990, pp 590-591.
32. Stone PJ, Lucey EC, Snider GL, et al: Effect of diet on urinary excretion of desmosine and hydroxylysyl pyridinoline. Am J Respir Crit Care Med 1994;149:174-177.
33. James IT, Walne AJ, Perrett D: The measurement of pyridinium crosslinks: A methodological overview. Anal Clin Biochem 1996;33:397-420.
34. James IT, Perret D, Skingle L et al: A novel pyridinoline like crosslink in human bone and urine hydrolysates. In Christiansen C, Overgaard K (eds): Osteoporosis 1990: Proceedings of the Third International Symposium on Osteoporosis. Copenhagen, Osteopress ApS, 1990, pp 517-520.
35. Colwell A, Russell RGG, Eastell R: Factors affecting the assay of urinary 3-hydroxypyridinium cross-links of collagen as markers of bone resorption. Eur J Clin Invest 1993;23:341-349.
36. Black D, Duncan A, Robins SP: Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high performance liquid chromatography. Anal Biochem 1988;169:197-203.
37. Pratt DA, Daniloff Y, Duncan A, et al: Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase extraction and reversed-phase high-performance liquid chromatography. Anal Biochem 1992;207:168-175.
38. Yoshimura Y, Ohnishi K, Hamamura M, et al: Automated high-performance liquid chromatographic determination of hydoxylysylpyridinoline and lyslpyridinoline in urine using a column switching method. J Chromatogr 1993;613:43-49.
39. James IT, Walne AJ, Perret D: Automated solid phase extraction with HPLC analysis of pyridinium cross-links. Anal Biochem 1996:240:29-36.
40. Gunja-Smith Z, Boucek RJ: Collagen crosslinking compounds in human urine. Biochem J 1981;197:759-762.
41. Koob TJ, Eyre DR, Van Ness KP: Detection and photolysis of hydroxypyridinium crosslinks in cartilage collagen in situ. Trans Ann Meet Orthopaed Res USA 1983;28.
42. James IT, Perrett D, Thompson PW: Rapid assay for hard tissue collagen crosslinks using isocratic ion-pair reversed-phase liquid chromatography. J Chromatogr 1990;525:43-57.
43. Lichy A, Macek J, Adam M: Determination of hydroxylysylpyridinoline in tissues and urine by high-performance liquid chromatography. J Chromatogr 1991;563:153-157.
44. Colwell A, Eastell R, Al-Dehaimi A, et al: The measurement of 3-OH pyridinium compounds using high performance capillary electrophoresis. In Ring EFJ (ed), Current Research in Osteoporosis and Bone Mineral Measurement II (2nd edition). London, British Institute of Radiology, 1992, pp 5-6.
45. Robins SP, Duncan A, Riggs BL: Direct measurement of free hydroxypyridinium crosslinks of collagen in urine as new markers of bone resorption in osteoporosis. In Christiansen C, Overgaard K (eds): Osteoporosis 1990: Proceedings of the Third International Symposium on Osteoporosis. Copenhagen, Osteopress ApS, 1990, pp 465-468.
46. Engler H, Riesen W: Pyridinium-cross-links: Sind die resultate der freien PYD, DPD-bestimmung als knochen-resorptionsmarker vergleichbar zu denjenigen der gesamt-PYD, DPD-konzentration? Clin Lab 1995;41:893-895.
47. Robins SP, Woitge H, Hesley R, et al: Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 1994;9:1643-1649.
48. Gomez Jr B, Ardakani S, Evans BJ, et al: Monoclonal antibody assay for free urinary pyridinium cross-links. Clin Chem 1996;42:1168-1175.
49. Blumsohn A, Hannon RH, Wrate R, et al: Biochemical markers of bone turnover in girls during puberty. Clin Endocrinol 1994;40:663-670.
50. Garnero P, Gineyts E, Arbault P, et al: Different effects of bisphosphonate and estrogen therapy on the excretion of free and peptide-bound crosslink excretion. J Bone Miner Res 1995;10:641-649.
51. Prestwood KM, Pilbeam CC, Burleson JA, et al: The short term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab 1994;79:366-371.
52. Blumsohn A, Naylor KE, Assiri AMA, et al: Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget's disease. Clin Chem 1995;41:1592-1598.
53. Rosen HN, Dresner-Pollak R, Moses AC, et al: Specificity of urinary excretion of crosslinked N-telopeptides of type I collagen as a marker of bone turnover. Calcif Tissue Int 1994;54:26-29.
54. Kamel S, Brazier M, Picard C, et al: Urinary excretion of pyridinoline crosslinks measured by immunoassay and HPLC techniques in normal subjects and in elderly patients with vitamin D deficiency. Bone Miner 1994;26:197-208.
55. Ju HJ, Leung S, Brown B, et al: Comparison of analytical performance and biological variability of three bone resorption assays. Clin Chem 1997;43:1570-1576.
56. Robins SP: An enzyme-linked immunoassay for the collagen crosslink pyridinoline. Biochem J 1982;207:617-620.
57. Seyedin S, Kung VT, Daniloff YN, et al: Immunoassay for urinary pyridinoline: The new marker of bone resorption. J Bone Miner Res 1993;8:635-641.
58. Gomez G Jr, Ardakani S, Evans BJ, et al: Monoclonal antibody assay for free urinary pyridinium crosslinks. Clin Chem 1996;42:1168-1175.
59. Laurie D, Barnes AK, Burgess KJ, et al: A coated tube radioimmunoassay (RIA) for the measurement of deoxypyridinoline in urine. J Bone Miner Res 1996;11(Supp 1):(Abstract S403)S190.
60. Martens MFWC, van Hoek MJC, Rosmalen FMA: Measurement of clinical samples with a new radioimmunoassay to measure deoxypyridinoline in urine and serum. J Bone Miner Res 1995;10 (Suppl):(Abstract M466)S368.
61. Wong SS, Srivastava AK, Baylink DJ, et al: Evaluation of the BioRad crosslinks kit for the HPLC measurement of pyridinium crosslinks. Clin Chem 1997;43(Suppl 6):(Abstract 318)S176.
62. ® System. Clin Chem 1997;43(Suppl 6):(Abstract 303)S173.
63. ® System. Clin Chem 1997;43(Suppl 6):(Abstract 352)S183.
64. Chen SY, Sickel M, Kline S, et al: Rapid urinary deoxypyridinoline measurement by an automated immunoassay. J Bone Miner Res 1996;11(Suppl 1):(Abstract S404)S191.
65. ® system. Clin Chem 1996;42(Suppl 6):(Abstract 064)S110.
66. Panteghini M, Pagani F: Biological variation in urinary excretion of pyridinium crosslinks: Recommendations for the optimum specimen. Ann Clin Biochem 1996;33:36-42.
67. Blumsohn A, Eastell R: The performance and utility of biochemical markers of bone turnover. Do we know enough to use them in clinical practice? Ann Clin Biochem 1997;34:449-459.
68. James I, Crowley C, Perrett D: Assay of pyridinium crosslinks in serum using narrow-bore ion-paired reversed-phase high-performance liquid chromatography. J Chromatog Biomed Appl 1993;612:41-48.
69. Abbiati G, Rigoldi M, Frignani S, et al: Determination of pyridinium cross-links in plasma and serum by high-performance liquid chromatography. J Chromatog Biomed Appl 1994;656:303-310.
70. Hata K, Miura M, Fukumoto S, et al: Assay of serum pyridinoline: A potential marker for bone resorption. Clin Chim Acta 1995;235:221-227.
71. Ibrahim S, Mojiminiyi S, Barron JL: High-performance liquid chromatographic determination of pyridinium crosslinks in serum, urine and dialysate of patients in chronic renal failure. Ann Clin Biochem 1996;33:31-35.
72. Urena P, Ferreira A, Kung VT, et al: Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in haemodialysis patients. J Bone Miner Res 1995;10:932-939.
73. Squire CR, Chesters CA, Fraser WD: Development and preliminary evaluation of a plasma free deoxypyridinoline radioimmunoassay. Proc ACB Nat Meet 1998;(Abstract 10)56.
74. Hampson G, Evans C, Chesters CA, et al: Bone turnover in patients with end-stage renal disease on dialysis. Proc ACB Nat Meet 1998;(Abstract 8)56.
75. Shaw NJ, Dutton J, Fraser WD, et al: Urinary pyridinoline and deoxypyridinoline excretion in children. Clin Endocrinol 1995;42:607-612.
76. Robins SP, Duncan A, Wilson N, et al: Standardization of pyridinium crosslinks, pyridinoline and deoxypyridinoline, for use as biochemical markers of collagen degradation. Clin Chem 1996;42:1621-1626.
77. Uebelhart D, Schlemmer A, Johansen J, et al: Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium crosslinks. J Clin Endocrinol Metab 1991;72:367-373.
78. Bettica P, Moro L, Robins SP, et al: Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks and hydroxyproline compared. Clin Chem 1992;38:2313-2318.
79. Delmas PD, Gineyts E, Bertholin A, et al: Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Miner Res 1993;8:643-648.
80. Schlemmer A, Hassager C, Jensen SB, et al: Marked diurnal variation in urinary excretion of pyridinium crosslinks in premenopausal women. J Clin Endocrinol Metab 1992;74:476-480.
81. Blumsohn A, Herrington K, Hannon R, et al: The effect of calcium supplementation on the circadian rhythm of bone resorption. J Clin Endocrinol Metab 1994;79:730-735.
82. McLaren AM, Isdale AH, Whiting PH, et al: Physiological variations in the urinary excretion of pyridinium crosslinks of collagen. Br J Rheumatol 1993;32:307-312.
83. Eastell R, Calvo MS, Burritt MF, et al: Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type 1 osteoporosis. J Clin Endocrinol Metab 1992;74:487-494.
84. Schlemmer A, Hassager C, Pedersen BJ, et al: Posture, age, menopause and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinks. J Bone Miner Res 1994;9:1883-1888.
85. Bollen A-M, Eyre D: Bone resorption rates in children monitored by the urinary assay of collagen type 1 crosslinked peptides. Bone 1994;15:31-34.
86. Abbiati G, Bartucci F, Longoni A, et al: Monitoring of free and total urinary pyridinoline and deoxypyridinoline in healthy volunteers: Sample relationships between 24-h and fasting early morning urine concentrations. Bone Miner 1993;21:9-19.
87. Gerrits MI, Thijssen JHH, van Rijn HJM: Determination of pyridinoline and deoxypyridinoline in urine, with special attention to retaining their stability. Clin Chem 1995;41:571-574.
88. Schlemmer A, Hassager C, Risteli J, et al: Possible variation in bone resorption during the normal menstrual cycle. Acta Endocrinol 1993;129:388-392.
89. Seibel MJ, Woitge H, Scheidtnave G, et al: Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study. J Bone Miner Res 1994;9:1433-1440.
90. Branca F, Robins SP, Ferro-Luzzi A, et al: Bone turnover in malnourished children. Lancet 1992;340:1493-1496.
91. Newland P, Black A, Beastall GH, et al: Changes in PTH(1-84) pulsatility and urinary crosslinks excretion during a 96h fast in 3 male volunteers. Proc XVI Int Congr Clin Chem 1996;(Abstract B20)203.
92. Hatori M, Hasegawa A, Adachi H, et al: The effects of walking at the anaerobic threshold level on vertebral bone loss in post menopausal women. Calcif Tissue Int 1993;52:411-414.
93. Hetland ML, Haarbo J, Christiansen C: Low bone mass and high bone turnover in male long distance runners. J Clin Endocrinol Metab 1993;77:770-775.
94. Caillot-Augusseau A, Lafage-Proust M-H, Soler C, et al: Bone formation and resorption biological markers in cosmonauts during and after a 180-day space flight (Euromir 95). Clin Chem 1998;44:578-585.
95. Gallacher SJ, Fraser WD, Owens OJ, et al: Changes in calcitrophic hormones and biochemical markers of bone turnover in normal human pregnancy. Eur J Endocrinol 1994;131:369-374.
96. Black AJ, Topping J, Farquharson R, et al: Bone metabolism in pregnancy: A review. Contemp Rev Obstet Gynaecol 1996;8:192-196.
97. Marowska J, Kobylinska M, Lukaszkiewicz J, et al: Pyridinium crosslinks of collagen as a marker of bone resorption rates in children and adolescents: Normal values and clinical application. Bone 1996;19:669-677.
98. Tillman V, Birkinshaw G, Fraser WD, et al: Short-term changes in growth and in urinary pyridinoline and deoxypyridinoline excretion in 7 healthy prepubertal children. J Endocrinol 1998;156(Suppl):(Abstract)140.
99. Fujimoto S, Kubo T, Tanaka H, et al: Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiency. J Clin Endocrinol Metab 1995;80:1922-1928.
100. Body JJ, Delmas PD: Urinary pyridinium crosslinks as markers of bone resorption in tumour-associated hypercalcaemia. J Clin Endocrin Metab 1992;74:471-475.
101. Seibel MJ, Gartenberg F, Silverberg SJ, et al: Urinary hydroxypyridinium crosslinks of collagen in primary hyperparathyroidism. J Clin Endocrinol Metab 1992;74:471-475.
102. Ohishi T, Kushida K, Takahashi M, et al: Urinary bone resorption markers in patients with metabolic bone disorders. Bone 1994;15:15-20.
103. MacDonald AG, Birkinshaw G, Durham B, et al: Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity. Brit J Rheumatol 1997;36:50-53.
104. Alvarez L, Guanabens N, Peris P, et al: Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease. J Bone Miner Res 1995;10:458-465.
105. Black D, Marabani M, Sturrock RD, et al: Urinary excretion of the hydroxypyridinium crosslinks of collagen in patients with rheumatoid arthritis. Ann Rheum Dis 1989;48:641-644.
106. Uebelhart D, Gineyts EC, Chapuy MC, et al: Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner 1990;8:87-96.
107. Seibel MJ, Cosman F, Shen V, et al: Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and oestrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 1993;8:881-889.
108. Eastell R, Robins SP, Colwell T, et al: Evaluation of bone turnover in type 1 osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteporosis Int 1993;3:255-260.
109. Thompson PW, Spector TD, Edwards AC, et al: Urinary deoxypyridinoline and serum osteocalcin as measures of bone metabolism in early postmenopausal women: distribution and comparison with other measures. In Christiansen C, Overgaard K (eds): Osteoporosis 1990: Proceedings of the Third International Symposium on Osteoporosis. Copenhagen, Osteopress Aps 1990, pp 493-495.
110. Melton LJ, Khosla S, Atkinson EJ, et al: Relationship of bone turnover to bone density and fractures. J Bone Miner Res 1997;12:1083-1091.
111. Garnero P, Hausherr E, Chapuy MC, et al: Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study. J Bone Miner Res 1996;11:1531-1538.
112. Riggs BL, O'Fallon W, Muhs J, et al: Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res 1998;13:168-174.
113. Randall AG, Kent GN, Garcia-Webb P, et al: Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links. J Bone Miner Res 1996;11:1176-1184.
114. Chesnut CH, McClung MR, Ensrud KE, et al: Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling. Am J Med 1995;99:144-152.